ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Strategic Plan To be Unveiled In San Antonio

January 31, 1992

Obit: Same Shapiro, Proponent of Mammographic Screening.

January 7, 2000

Donald Coffey Is President-Elect Of NCCR; Coalition Elects Five New Board.

January 28, 2000

Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released.

July 10, 2009

Researchers Find Two Types Of MCL Drug Resistance

August 29, 2014

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995